Human papillomavirus 16 E7 inactivator of retinoblastoma family proteins complements human cytomegalovirus lacking UL97 protein kinase.
about
Cyclin-dependent kinase-like function is shared by the beta- and gamma- subset of the conserved herpesvirus protein kinasesCyclin A degradation by primate cytomegalovirus protein pUL21a counters its innate restriction of virus replication.Human cytomegalovirus protein pUL117 targets the mini-chromosome maintenance complex and suppresses cellular DNA synthesis.Quantitative temporal viromics: an approach to investigate host-pathogen interactionAn epistatic relationship between the viral protein kinase UL97 and the UL133-UL138 latency locus during the human cytomegalovirus lytic cycle.Inactivation and disassembly of the anaphase-promoting complex during human cytomegalovirus infection is associated with degradation of the APC5 and APC4 subunits and does not require UL97-mediated phosphorylation of Cdh1.A novel CDK7 inhibitor of the Pyrazolotriazine class exerts broad-spectrum antiviral activity at nanomolar concentrations.A viral regulator of glycoprotein complexes contributes to human cytomegalovirus cell tropism.The retinoblastoma tumor suppressor promotes efficient human cytomegalovirus lytic replicationAntagonistic Relationship between Human Cytomegalovirus pUL27 and pUL97 Activities during Infection.Herpes simplex viruses: mechanisms of DNA replication.Sites and roles of phosphorylation of the human cytomegalovirus DNA polymerase subunit UL44.Contribution of retinoblastoma LOH and the p53 Arg/Pro polymorphism to cervical cancer.The ULb' region of the human cytomegalovirus genome confers an increased requirement for the viral protein kinase UL97.Human cytomegalovirus pUL97 regulates the viral major immediate early promoter by phosphorylation-mediated disruption of histone deacetylase 1 binding.Hsp90 inhibitor 17-DMAG decreases expression of conserved herpesvirus protein kinases and reduces virus production in Epstein-Barr virus-infected cellsHuman Cytomegalovirus Can Procure Deoxyribonucleotides for Viral DNA Replication in the Absence of Retinoblastoma Protein Phosphorylation.Congenital cytomegalovirus infection: molecular mechanisms mediating viral pathogenesis.Comparison of effects of inhibitors of viral and cellular protein kinases on human cytomegalovirus disruption of nuclear lamina and nuclear egress.Inhibition of cellular STAT3 synergizes with the cytomegalovirus kinase inhibitor maribavir to disrupt infection.Inactivation of retinoblastoma protein does not overcome the requirement for human cytomegalovirus UL97 in lamina disruption and nuclear egress.A mutation deleting sequences encoding the amino terminus of human cytomegalovirus UL84 impairs interaction with UL44 and capsid localizationThe Epstein-Barr virus (EBV)-encoded protein kinase, EBV-PK, but not the thymidine kinase (EBV-TK), is required for ganciclovir and acyclovir inhibition of lytic viral productionSimian virus 40 T/t antigens and lamin A/C small interfering RNA rescue the phenotype of an Epstein-Barr virus protein kinase (BGLF4) mutant.Human cytomegalovirus UL97 phosphorylates the viral nuclear egress complexHATs on for drug resistance.
P2860
Q28475457-A928BE7D-579F-4614-AC12-699C2D7EE676Q30415421-DA78FDF5-611B-4996-9F50-84179F2CDEE2Q33545226-EFB2FF29-C352-47BC-B1FA-5FE7470D896BQ33722378-E94D26B6-7DE2-441B-8DA3-9BD7F860E378Q33887700-4E031C82-2EBF-49EA-ACFA-D3F0B11A9DD0Q34178268-19D43466-46D5-43AA-8864-1366BAAE8CE7Q35168968-6EEE270F-E793-48EA-8B50-D7A8917E62C0Q35378089-B715DD94-F400-43D1-B3DB-10DDABFE198AQ35488900-BC79A37C-63D0-47EF-AAA8-68C5DC2CDA15Q36086320-C1E099EF-039E-4D86-940A-324FFE5CC273Q36192926-BCB3CE93-3C64-4572-9B5D-855A803199CAQ36212341-BD2CEEF7-4BB1-4C83-AB39-EE8E64ED65EEQ36383234-3D4221B2-5404-4572-8AA5-7D8FC3AE9B79Q36827232-F075ACA1-9BCB-4860-8A6E-02271632768BQ36978826-FD74F7BE-2AF2-4E9C-B158-71354511ECA2Q37123188-3B3E68E9-C12B-4127-B7E9-DBE3A842A70BQ37252945-1FF86C91-FE80-4662-90CC-F2491133728BQ37406553-4D319AC8-4CC0-4E66-A652-74039468A4A8Q38981231-6DB222A9-DF03-425A-A74D-C0BF993D03CBQ39091219-D408281B-D9E0-46FD-B8E4-87DBC4A24905Q39191174-5EC9F364-A884-4699-BDCF-494CA571BD74Q39303829-4CBAD911-49A2-42B9-B0E3-E05C4895BF29Q39735571-A4D4A9F7-42AB-4A80-BF63-80B0AD840971Q39741182-03D2DBB4-04DD-4E84-A36D-E165639E7C29Q41691057-CE705D10-A410-4697-9D0F-3C5E3D4CBC33Q42712360-ACC57D45-9F60-4DBE-8AE6-8A0FB9F598A6
P2860
Human papillomavirus 16 E7 inactivator of retinoblastoma family proteins complements human cytomegalovirus lacking UL97 protein kinase.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Human papillomavirus 16 E7 ina ...... s lacking UL97 protein kinase.
@en
Human papillomavirus 16 E7 ina ...... s lacking UL97 protein kinase.
@nl
type
label
Human papillomavirus 16 E7 ina ...... s lacking UL97 protein kinase.
@en
Human papillomavirus 16 E7 ina ...... s lacking UL97 protein kinase.
@nl
prefLabel
Human papillomavirus 16 E7 ina ...... s lacking UL97 protein kinase.
@en
Human papillomavirus 16 E7 ina ...... s lacking UL97 protein kinase.
@nl
P2093
P2860
P50
P356
P1476
Human papillomavirus 16 E7 ina ...... us lacking UL97 protein kinase
@en
P2093
Donald M Coen
Karl Münger
Robert F Kalejta
P2860
P304
16823-16828
P356
10.1073/PNAS.0901521106
P407
P577
2009-09-15T00:00:00Z